EFNB2 and neoplasm: Sequencing of the CpG island associated with the ephrinB2 promoter region following sodium bisulfite treatment of the DNA revealed aberrant methylation of CpG sites in the tumour DNA of 34.6% of all investigated glioma patients, while no methylation was observed in normal brain (Fig. 1c).